VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms
Cell Reports · 2024-01 · 43 (1) · 113661
DOI: 10.1016/j.celrep.2023.113661 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-01. Verfasst von Keman Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Hematology and Oncology Research, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Neoplasms. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Myeloid-derived suppressor cells (MDSCs) impair antitumor immune responses. Identifying regulatory circuits during MDSC development may bring new opportunities for therapeutic interventions. We report that the V-domain suppressor of T cell activation (VISTA) functions as a key enabler of MDSC differentiation. VISTA deficiency reduced STAT3 activation and STAT3-dependent production of polyamines, which causally impaired mitochondrial respiration and MDSC expansion. In both mixed bone marrow (BM) chimera mice and myeloid-specific VISTA conditional knockout mice, VISTA deficiency significantly reduced tumor-associated MDSCs but expanded monocyte-derived dendritic cells (DCs) and enhanced T cell-mediated tumor control. Correlated expression of VISTA and arginase-1 (ARG1), a key enzyme supporting polyamine biosynthesis, was observed in multiple human cancer types. In human endometrial cancer, co-expression of VISTA and ARG1 on tumor-associated myeloid cells is associated with poor survival. Taken together, these findings unveil the VISTA/polyamine axis as a central regulator of MDSC differentiation and warrant therapeutically targeting this axis for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Hematology and Oncology Research, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, USA.
- Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, USA.
- Imaging Core Facility, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, USA.
- Department of Cancer Biology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, USA.
- Department of Pathology, University Hospitals Cleveland Medical Center, and Case Western Reserve University School of Medicine, Cleveland, OH, USA; Case Comprehensive Cancer Center, Cleveland, OH, USA.
- Department of Translational Hematology and Oncology Research, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, USA. Electronic address: wangl9@ccf.org.
Förderung
- NCI NIH HHS
Zitieren
APA
Zhang, K., Zakeri, A., Alban, T., Dong, J., Ta, H. M., Zalavadia, A. H., Branicky, A., Zhao, H., Juric, I., Husich, H., Parthasarathy, P. B., Rupani, A., Drazba, J. A., Chakraborty, A. A., Ching-Cheng Huang, S., Chan, T., Avril, S., & Wang, L. L. (2024). VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms. Cell Reports, 43(1), 113661. https://doi.org/10.1016/j.celrep.2023.113661
Vancouver
Zhang K, Zakeri A, Alban T, Dong J, Ta HM, Zalavadia AH, et al. VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms. Cell Reports. 2024;43(1):113661. doi:10.1016/j.celrep.2023.113661
BibTeX
@article{Zhang2024,
author = {Zhang, Keman and Zakeri, Amin and Alban, Tyler and Dong, Juan and Ta, Hieu M and Zalavadia, Ajay H and Branicky, Andrelie and Zhao, Haoxin and Juric, Ivan and Husich, Hanna and Parthasarathy, Prerana B and Rupani, Amit and Drazba, Judy A and Chakraborty, Abhishek A and Ching-Cheng Huang, Stanley and Chan, Timothy and Avril, Stefanie and Wang, Li Lily},
title = {VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {1},
pages = {113661},
doi = {10.1016/j.celrep.2023.113661}
}
EUVIMED